Long-term Risks of Invasive Cervical Cancer Following HPV Infection: Follow-up of Two Screening Cohorts in Manchester

Overview

Journal Br J Cancer

Specialty Oncology

Date 2023 Mar 24

PMID 36959379

Authors

Clare Gilham

Alexandra Sargent

Emma J Crosbie

Julian Peto

Affiliations

Soon will be listed here.

Abstract

Background: Long-term follow-up of large cohorts is needed to determine the effects of HPV and screening on CIN3 (grade 3 cervical intraepithelial neoplasia) and ICC (invasive cervical cancer).

Methods: Women were recruited when attending for routine cervical screening in Greater Manchester, UK: 1987-93 for the Manchester Cohort (MC: 47,625 women) and 2001-03 for the ARTISTIC Cohort (AC: 24,496 women). Both were followed through national registration for cancer incidence and mortality to 2020.

Results: Risk patterns following HPV infection differed for CIN3 and ICC. Risk of ICC in the MC rises for 30 years following a single positive HPV test, reaching 2.5% (95% CI: 1.3-4.5%). A similar pattern was seen in the AC, but the risks of cancer were approximately halved. CIN3 was diagnosed much sooner in the AC due to more efficient cytology. More sensitive HPV testing was able to better predict future risk.

Conclusion: The sensitivity of HPV testing and cytology influences the CIN3 detection rate. Sensitive HPV testing enables effective risk stratification. Increased risk of ICC is observed 15-30 years after HPV infection. Women testing HPV + should be followed until their infection clears. Discharging women from screening programmes whilst they remain HPV + may not be safe, even if cytology and colposcopy tests are normal.

Citing Articles

Clinical glycoproteomics: methods and diseases.

Wang Y, Lei K, Zhao L, Zhang Y MedComm (2020). 2024; 5(10):e760.

PMID: 39372389 PMC: 11450256. DOI: 10.1002/mco2.760.

Cervical HPV infection and related diseases among 149,559 women in Fujian: an epidemiological study from 2018 to 2023.

Lin K, Hong Q, Fu Y, Tu H, Lin H, Huang J Front Microbiol. 2024; 15:1418218.

PMID: 38962121 PMC: 11220154. DOI: 10.3389/fmicb.2024.1418218.

Implications of viral infections and oncogenesis in uterine cervical carcinoma etiology and pathogenesis.

Chu D, Liu T, Yao Y Front Microbiol. 2023; 14:1194431.

PMID: 37293236 PMC: 10244558. DOI: 10.3389/fmicb.2023.1194431.

References

Peto J, Gilham C, Fletcher O, Matthews F . The cervical cancer epidemic that screening has prevented in the UK. Lancet. 2004; 364(9430):249-56. DOI: 10.1016/S0140-6736(04)16674-9. View

Landy R, Pesola F, Castanon A, Sasieni P . Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case-control study. Br J Cancer. 2016; 115(9):1140-1146. PMC: 5117785. DOI: 10.1038/bjc.2016.290. View

Ronco G, Dillner J, Elfstrom K, Tunesi S, Snijders P, Arbyn M . Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet. 2013; 383(9916):524-32. DOI: 10.1016/S0140-6736(13)62218-7. View

Rebolj M, Rimmer J, Denton K, Tidy J, Mathews C, Ellis K . Primary cervical screening with high risk human papillomavirus testing: observational study. BMJ. 2019; 364:l240. PMC: 6364146. DOI: 10.1136/bmj.l240. View

Rebolj M, Cuschieri K, Mathews C, Pesola F, Denton K, Kitchener H . Extension of cervical screening intervals with primary human papillomavirus testing: observational study of English screening pilot data. BMJ. 2022; 377:e068776. PMC: 9153243. DOI: 10.1136/bmj-2021-068776. View

Peto J, Gilham C, Deacon J, Taylor C, Evans C, BINNS W . Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort. Br J Cancer. 2004; 91(5):942-53. PMC: 2409880. DOI: 10.1038/sj.bjc.6602049. View

Gilham C, Sargent A, Kitchener H, Peto J . HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT. Health Technol Assess. 2019; 23(28):1-44. PMC: 6600121. DOI: 10.3310/hta23280. View

de Martel C, Plummer M, Vignat J, Franceschi S . Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017; 141(4):664-670. PMC: 5520228. DOI: 10.1002/ijc.30716. View

Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage J, Castle P . Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst. 2011; 103(5):368-83. PMC: 3046952. DOI: 10.1093/jnci/djq562. View

10.

Arbyn M, Bergeron C, Klinkhamer P, Martin-Hirsch P, Siebers A, Bulten J . Liquid compared with conventional cervical cytology: a systematic review and meta-analysis. Obstet Gynecol. 2008; 111(1):167-77. DOI: 10.1097/01.AOG.0000296488.85807.b3. View

11.

Kitchener H, Almonte M, Thomson C, Wheeler P, Sargent A, Stoykova B . HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. Lancet Oncol. 2009; 10(7):672-82. DOI: 10.1016/S1470-2045(09)70156-1. View

12.

Jorgensen S, Andersen B, Petersen L, Rebolj M, Njor S . Adherence to follow-up after the exit cervical cancer screening test at age 60-64: A nationwide register-based study. Cancer Med. 2021; 11(1):224-237. PMC: 8704149. DOI: 10.1002/cam4.4420. View

13.

Dijkstra M, van Zummeren M, Rozendaal L, van Kemenade F, Helmerhorst T, Snijders P . Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands. BMJ. 2016; 355:i4924. DOI: 10.1136/bmj.i4924. View

14.

Hasegawa Y, Ando M, Kubo A, Isa S, Yamamoto S, Tsujino K . Human papilloma virus in non-small cell lung cancer in never smokers: a systematic review of the literature. Lung Cancer. 2013; 83(1):8-13. DOI: 10.1016/j.lungcan.2013.10.002. View

15.

Deacon J, Evans C, Yule R, Desai M, BINNS W, Taylor C . Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort. Br J Cancer. 2000; 83(11):1565-72. PMC: 2363425. DOI: 10.1054/bjoc.2000.1523. View

16.

Almonte M, Dos Santos Silva I, Asare A, Gilham C, Sargent A, Bailey A . Sexual behavior and HPV infection in British women, by postal questionnaires and telephone interviews. J Med Virol. 2011; 83(7):1238-46. DOI: 10.1002/jmv.22085. View